Stephen Andrew Moore (S A Moore, Stephen Moore)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 8

Top Topics

Top Venues

Antibiotics (Basel, Switzerland)

Clinical and experimental dermatology

Journal of the European Academy of Dermatology and Venereology : JEADV

International journal of dermatology

This page only lists publications with an associated author ORCID identifier.

Publications

Angela Yen Moore, Kara Hurley, Stephen Andrew Moore
A Post Hoc Analysis of Efficacy Data on Sarecycline in Hispanics with Acne from Two Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trials. Antibiotics (Basel, Switzerland) 12 (1) (2023)
Angela Yen Moore, Kara Hurley, Stephen Andrew Moore, Luke Moore, Ilana Zago
Effect of Sarecycline on the Acne Symptom and Impact Scale and Concerns in Moderate-to-Severe Truncal Acne in Open-Label Pilot Study. Antibiotics (Basel, Switzerland) 12 (1) (2023)
Angela Yen Moore, Kara Hurley, Stephen Andrew Moore, Luke Moore, Ilana Zago
Effect of Sarecycline on the Acne Symptom and Impact Scale and Concerns in Moderate-to-Severe Truncal Acne in Open-Label Pilot Study. Antibiotics (Basel, Switzerland) 12 (1) (2023)
Angela Yen Moore, Kara Hurley, Stephen Andrew Moore
A Post Hoc Analysis of Efficacy Data on Sarecycline in Hispanics with Acne from Two Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trials. Antibiotics (Basel, Switzerland) 12 (1) (2023)
Angela Yen Moore, Kara Hurley, Stephen Andrew Moore
A Post Hoc Analysis of Efficacy Data on Sarecycline in Hispanics with Acne from Two Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trials. Antibiotics (Basel, Switzerland) 12 (1) (2023)
A Y Moore, Stephen Andrew Moore, Q He, P Rady, Stephen K Tyring
Tirbanibulin 1% ointment eradicates HPV-16 (+) vulvar high-grade squamous intraepithelial lesion. Journal of the European Academy of Dermatology and Venereology : JEADV 36 (10) (2022)
Stephen Andrew Moore, Deepika Narayanan, Rebecca A Simonette, Brooke Randi Bartley, Hung Quoc Doan, Peter L Rady, Stephen K Tyring
Selinexor is a novel inhibitor of DNA damage response in Merkel cell carcinoma. Clinical and experimental dermatology 47 (7) (2022)
Stephen Andrew Moore, Peter Rady, Stephen Tyring
Acquired epidermodysplasia verruciformis: clinical presentation and treatment update. International journal of dermatology (2021)